Simultaneous Determination and Validation of Hydrochlorothiazide & Eprosartan in bulk drug and Marketed Formulation by Rp-Hplc
Main Article Content
Abstract
Validation of developed and RP HPLC analytical method according to ICH Guidelines. A review of
literature reveals that no analytical methods are available for these drugs. There are no methods in the
literature for the estimation of drugs in combined dosage forms. Analytical methods have been report for
hydrochlorothiazide and eprosartan using RP-HPLC in pharmaceutical dosage form. The development of
simple and precise reverse phase high performance liquid chromatography of hydrochlorothizide and
eprosartan using single method in bulk in bulk drug and market formulation.
literature reveals that no analytical methods are available for these drugs. There are no methods in the
literature for the estimation of drugs in combined dosage forms. Analytical methods have been report for
hydrochlorothiazide and eprosartan using RP-HPLC in pharmaceutical dosage form. The development of
simple and precise reverse phase high performance liquid chromatography of hydrochlorothizide and
eprosartan using single method in bulk in bulk drug and market formulation.
Downloads
Download data is not yet available.
Article Details
How to Cite
Patel, A. (2017). Simultaneous Determination and Validation of Hydrochlorothiazide & Eprosartan in bulk drug and Marketed Formulation by Rp-Hplc. International Journal of Pharmaceutical & Biological Archive, 8(1). https://doi.org/10.22377/ijpba.v8i1.1514
Section
Research Articles
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.